Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-01-02
2007-01-02
Wax, Robert A. (Department: 1653)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C424S045000, C424S450000, C530S324000, C530S399000
Reexamination Certificate
active
10768288
ABSTRACT:
Pharmaceutical compositions and methods are described comprising at least one Y2 receptor-binding peptide, such as peptide YY(PYY), Neuropeptide Y (NPY) or Pancreatic Peptide (PP) and one or more mucosal delivery-enhancing agents for enhanced nasal mucosal delivery of the peptide YY, for treating a variety of diseases and conditions in mammalian subjects, including obesity.
REFERENCES:
patent: 5134127 (1992-07-01), Stella et al.
patent: 5308620 (1994-05-01), Yen
patent: 5574010 (1996-11-01), McFadden
patent: 5604203 (1997-02-01), Balasubramaniam
patent: 5616311 (1997-04-01), Yen
patent: 5696093 (1997-12-01), Tseng et al.
patent: 5716643 (1998-02-01), Yen
patent: 5725804 (1998-03-01), Yen
patent: 5759565 (1998-06-01), Azria et al.
patent: 5912227 (1999-06-01), Croom, Jr. et al.
patent: 5945033 (1999-08-01), Yen
patent: 5968748 (1999-10-01), Bennett et al.
patent: 5977175 (1999-11-01), Lin
patent: 5980945 (1999-11-01), Ruiz
patent: 6013285 (2000-01-01), Yen
patent: 6013633 (2000-01-01), Balasubramanium
patent: 6017879 (2000-01-01), Mutter et al.
patent: 6046167 (2000-04-01), Balasubramaniam
patent: 6046177 (2000-04-01), Stella et al.
patent: 6191102 (2001-02-01), DiMarchi et al.
patent: 6235718 (2001-05-01), Balasubramanium et al.
patent: 6264988 (2001-07-01), Yen
patent: 6391343 (2002-05-01), Yen
patent: 6558708 (2003-05-01), Lin
patent: 6583111 (2003-06-01), DiMarchi et al.
patent: 6737408 (2004-05-01), Balasubramanium et al.
patent: 2002/0197324 (2002-12-01), Watts et al.
patent: 2004/0228846 (2004-11-01), Pang et al.
patent: 2005/0176630 (2005-08-01), Cowley et al.
patent: 1 091 194 (2003-05-01), None
patent: 1 288 223 (2003-05-01), None
patent: 1 288 224 (2003-05-01), None
patent: 0 678 018 (2003-09-01), None
patent: 1 466 610 (2004-10-01), None
patent: WO 94/22467 (1994-10-01), None
patent: WO 98/20885 (1998-05-01), None
patent: WO 99/02135 (1999-01-01), None
patent: WO 09915516 (1999-04-01), None
patent: WO 00/47219 (2000-08-01), None
patent: WO 02/47712 (2002-06-01), None
patent: WO 03/026591 (2003-04-01), None
patent: WO 03/057235 (2003-07-01), None
patent: WO 03/105763 (2003-12-01), None
Mei-Huei Chen; Balasubramanian; Murphy; Tabata; Fischer; Chen; Joffe, Sensitive Radioimmunoassay for Measurement of CI rculating Peptide YY, Gastroenterology, 1984, pp. 1332-1338, vol. 87, Publisher: American Gastroenterological Association, Published in: Cincinnati, Ohio.
Morley, John E.; Levine, Allen S.; Grace, Martha; Kneip, Julie, “Peptide YY (PYY), a potent orexigenic agent,” Brain Research, 1985, vol. 341, pp. 200-203. Elsevier Science Publishers.
John E. Morley and James F. Flood, An Investigation of Tolerance to the actions of Leptogenic and Anorexigenic Drugs in Mice, Life Sciences, Sep. 10, 1987, pp. 22157-2165, vol. 41, Publisher: Pergamon Journals, Published in: Sepulveda, CA, US.
Kazuhiko Tatemoto; Nakano; Makk; Angwin; Mann; Schilling; Go, Isolation and Primary Structure of Human Peptide YY, Biochemical and Biophysical Research Communications, Oct. 31, 1988, pp. 713-717, vol. 157(2), Publisher: Academic Press, Inc., Published in: Los Angeles, California, US.
Balasubramaniam, A.; Servin, A. L.; Rigel, D. F.; Rouyer-Fessard, C. R.; Laburthe, M. Syntheses and receptor affinities of partial sequences of peptide YY (PYY) Peptide.Research., date- 1988, vol. 1, No. 1, pp. 32-35.
John E. Morley, An approach to the development of drugs for appetite disorders, Neuropsychobiology, Date 1989, vol. 21, issue 1, pp. 22-30, Karger AG, Basel.
Eberlein, G. A.;Eysselein, V. E.; Schaeffer, M.; Layer, P.;Grandt, D.;Goebell, H.;Niebel, W.; Davis, M.;Lee, T.D.; Shively,J.E.; Reeve, J. R., Jr.; A new molecular form of PYY; structural characterization of human PYY(3-36) and PYY(1-36) Peptides, DATE- 1989, vol. 10, No. 4, pp. 797-803, Pergamon Press, US.
Eysselein, V. E.;Eberlein, G. A.;Grandt, D.;Schaeffer, m.;Zehres, B.; Behn, U.;Schaefer, D.; Goebell, H.;Davis, M.; Lee,T. D.; Shively, J. E.; Meyer, H. E.; Reeve, J. R., Jr, Structural characterization of canine PYY, Peptides, Jun. 15, 1989, vol. 11, pp. 111-116, Pergamon Press, US.
Hiroyuki Minakata, Takashi Iwashita, Synthesis of analogues of peptide YY with modified N-terminal regions; relationships of amphiphilic secondary structures and activity in rat vas deferens, Journal: Biopolymers, vol. 29, Jan. 29, 1990, pp. 61-67, John Wiley & Sons, Inc.
Ramo, O. J.; Balasubramaniam, A.; Sheriff, S.; Rogers, D. H.; McCullough, P. J.; Bell, R. H., Jr., Neuropeptide Y and peptide YY stimulate the growth of exocrine pancreatic carcinoma cells, Neuropeptides, 1990, vol. 15, pp. 101-106, Longman Group UK.
S.F. Leibowitz, J.T. Alexander, Analysis of Neuropeptide Y-Induced Feeding: Dissociation of Y1 and Y2 Receptor Effects on Natural Meal Patterns, Peptides, Jul. 25, 1991, pp. 1251-1260, vol. 12, Publisher: Pergamon Press, Published in: New York, US.
Marc Laburthe, Peptide YY et neuropeptide Y dans L'intesin: disponibilite, effets biologiques et recepteurs epitheliaux, [translated title: Peptide YY and neutopeptide Y in the intestine: availability, biologic effects and epithelial receptors] Arch Int. Physiol Biochim Biophys, Reunion Complementaire de Physiologie, Association des Physiologistes. Toulouse 26-27, Apr. 1991, France.
Inui Akio, Minoru Okita, Masaharu Nakajima, Toru Inoue, Noriaki Sakatani, Manabu Oya, Hideki Morioka, Yasuhiko Okimura, Kazuo Chihara, and Shigeaki Baba, Neuropeptide regulation of feeing in dogs, Neuropeptides and Food Intake, 1991, pp. R5888-R594, 0363-6119, The American Physiologial Society.
Grandt, D.; Teyssen, S.; Schimiczek, M.; Reeve, J. R., Jr.; Feth, F.; Rascher, W.; Hirche, H.; Singer, M. V.; Layer, P.; Goebell, H.; Ho, F.J.; Eysselein, V.E.: Novel generation of hormone receptor specificity by amino terminal processing of peptide YY, Biochemical and Biophysical Research Communications, Aug. 14, 1992, vol. 186, No. 3, pp. 1299-1306, Academic Press, Inc.
S. Okada, Ohshima, Mori, K. Tatemoto, Peripherally not Centrally Administered Peptide YY(PYY) Decrease High Fat Diet Intake, Jun. 9, 1993, vol. 520, Publisher: Endocrinology, Published In: Gunmo, Japan.
Grandt, D.; Schimiczek, M.; Struk, K.; Shively, J.; Eysselein, V.E.; Goebell, H.; Reeve, J. R., JR—Characterization of two forms of peptide YY, PYY(1-36) and PYY(3-36) in the rabbit, Peptides, Jul. 29, 1994, vol. 15, No. 5, pp. 815-820, Pergamon, Elsevier Science Ltd, US.
Dumont, Yvan.; Cadieux, Alain.; Pheng, L. H.; Fournier, A.; St Pierre, S.; Quirion, R., Peptide YY derivatives as selective neuropeptide Y/peptide YY Y1and Y2agonist devoided of activity for the Y3receptor sub-type, Brain Research.Molecular.Brain Research, —Jun. 28, 1994, vol. 26, No. 1-2, pp. 320-324, Elsevier Science B.V.
Wlodarczyk-Bisaga K.; Bisaga A., Biologiczne aspekty zaburzen odzywiania sie-wybrane zagadnienia [Selected issues of biological aspects of eating disorders], Psychiatria Polska, Sep.-Oct. 1994; vol. 28, No. 5: pp. 579-591. Poland, abstract only.
Margaret Dos Santos Medeiros, M. D.; Anthony J. Turner, Processing and metabolism of peptide-YY: pivotal roles of dipeptidylpeptidase-IV, aminopeptidase-P, and endopeptidase-24.11, Endocrinology 1994, Vo 134, No. 5, pp. 2088-2094, The Endocrine Society, US.
Grandt, D.; Schimiczek, M.; Beglinger, C.; Layer, P.; Goebell, H.; Eysseleiin, V. E.; Reeve, J. R., Jr, Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36, Regulatory Peptides, May 5, 1994, vol. 51, No. 2, pp. 151-159, elsevier Sciences B.V.
Kazuhiko Tatemono, New Developments in Research on digestive tract hormones, Progress in Medicine, vol. 15, No. 9, date Sep. 1995, pp. 1793-1804, 46thPepsin Research Meeting (translated from Japanese) JP.
Norio Tani, Digestive Tract Hormones, Digestive Tract, 1996, Article Ser. No. 0012 (translated from Japanese) JP.
Gue, M.: Junien, J. L.: Reeve, J. R., Jr.; Rivier, J.; Grandt, D.; Tache, Y, Reversal by NPY, PYY and 3-36 molecular forms of NPY and PYY of intracisternal CRF-induced inhibition of gastric acid secretion in rats, British Journal o
Brandt Gordon
Kleppe Mary S.
MacEvilly Conor J.
Quay Steven C.
Knudsen Peter J.
Kosson Rosanne
Nastech Pharmaceutical Company Inc.
Wax Robert A.
LandOfFree
Compositions and methods for enhanced mucosal delivery of Y2... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for enhanced mucosal delivery of Y2..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for enhanced mucosal delivery of Y2... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3824330